BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

Biotechnology company developing first-of-its-kind, autologous stem cell therapies for the treatment of neurodegenerative diseases such as ALS, MS, PD.
Founded
2004
Raised
$35.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
Team Size
10+
Employees
$16,000,000 Grant
prnewswire

Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS

$2,100,000 Grant
Drug Delivery Business

Brainstorm lands $2.1m Israeli grant for NurOwn stem cell therapy